Schedule 13D ownership disclosure

Adamis Pharmaceuticals Corp

Security class unavailable · CUSIP: 00547W208

Event date: 2017-04-26

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-17-028422
Form type
SC 13D/A
Filer
DMK PHARMACEUTICALS Corp
CIK
CIK 887247
Filed
May 18, 2017
Reporting period
Apr 26, 2017
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub